Skip to main content
Premium Trial:

Request an Annual Quote

New Products: NanoInk’s NanoArray Assay System and More


NanoInk this week released its new NanoArray Assay System for the automated analysis of its protein NanoArray assays.

The system is intended for detection, identification, and quantitation of proteins for applications including biomarker analysis, translational medicine, and toxicology. The automated Assay System brings additional precision and higher throughput to NanoArray assays, the company said.

Promega this week introduced four new proteases – Pepsin, Elastase, Sequencing Grade Arg-C, and Thermolysin – for mass spec protein sample prep.

The proteases are provided in a lyophilized format and are intended for use for peptide mapping, protein identification, and characterization of post-translational modifications.

Epitomics this week announced the release of new rabbit monoclonal antibodies including ACAA2, MVD, OVOL2, and CD63.

Each antibody is validated in multiple applications and in multiple species including human, mouse, and rat.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.